AveXis (AVXS) News Today → It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad) Free AVXS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNovartis ‘focusing on high-end, innovative medicines,’ CEO saysfinance.yahoo.com - May 25 at 12:43 AMIonis Childhood Spine Disorder Drug Notches Pivotal Study Win, Triggers Biogen Optionthestreet.com - January 2 at 2:46 PMGoogle-backed gene therapy firm launches Morrisville manufacturing facility - The Business Journalsbizjournals.com - September 21 at 11:45 PMRegenxbio Stock: A Transformative Year (NASDAQ:RGNX) - Seeking Alphaseekingalpha.com - September 15 at 7:31 PMGenSight Biologics Strengthens Its Management Team to Support the Launch of LUMEVOQ® in Europe - Yahoo Financefinance.yahoo.com - September 12 at 3:49 AMREGENXBIO: Gene Therapy Pioneer Moving To Late-Stage Development (NASDAQ:RGNX) - Seeking Alphaseekingalpha.com - August 29 at 11:43 AMOnce high-flying Dallas biotech sees promising drug data amid growing financial pressure - The Dallas Morning Newsdallasnews.com - August 29 at 11:43 AMIt's in our DNA: Why the Columbus Region is a hub for gene therapy companies - Columbus Business First - The Business Journalsbizjournals.com - August 20 at 4:51 AMRelief Therapeutics Appoints David McCullough as Head of U.S. Market Access - StreetInsider.comstreetinsider.com - August 17 at 5:25 AMPopular Open Source GraphQL Company Dgraph Secures $6M in Seed Round with New Leadership - PR Newswireprnewswire.com - July 20 at 3:22 PMGeneration Bio Appoints Dannielle Appelhans to Its Board of Directors - GlobeNewswireglobenewswire.com - July 18 at 7:51 AMGlobal Cell and Gene Therapy Market Analysis/Opportunities Report 2022-2035: Niche Startups are Spearheading the Innovation in this Domain - Yahoo Financefinance.yahoo.com - June 9 at 11:15 PMGlobal Cell and Gene Therapy Market Analysis/Opportunities Report 2022-2035: Niche Startups are Spearheading the Innovation in this Domain - PR Newswireprnewswire.com - June 9 at 8:13 AMGlobal Cell and Gene Therapy Market Investor/Opportunities Report 2022: Evaluate the Current/Future Potential Over the Coming Decades - GlobeNewswireglobenewswire.com - June 8 at 4:58 PMBLUE stock drives gene therapy stocks higher after FDA review (NASDAQ:BLUE) - Seeking Alphaseekingalpha.com - June 7 at 8:56 PMSumo Logic Appoints John D. Harkey, Jr. to Board of Directors - Yahoo Financefinance.yahoo.com - May 3 at 8:08 PMSatellite Bio Reveals Pioneering Tissue Therapeutics, Bioengineered Tissues That Restore Organ Function, Bringing Hope Across Diseases - StreetInsider.comstreetinsider.com - April 21 at 7:01 PMRegenxbio: Is The Ultimate Catalyst Coming? - Seeking Alphaseekingalpha.com - April 20 at 2:55 PMSatellite Bio Reveals Pioneering Tissue Therapeutics, Bioengineered Tissues That Restore Organ Function, Bringing Hope Across Diseases - Business Wirebusinesswire.com - April 20 at 2:55 PMSamsung invests in Chicago biotech Jaguar Gene Therapy - The Business Journalsbizjournals.com - March 29 at 3:25 PMNkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors - Yahoo Financefinance.yahoo.com - March 29 at 10:17 AMTScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities - Yahoo Financefinance.yahoo.com - March 9 at 10:44 AMTaysha Gene Therapies Gets A 'Thumbs Up' - Seeking Alphaseekingalpha.com - March 7 at 6:53 PM'It's a real-life Hunger Games': a lifesaving drug costs $2m, but not every child can get it - The Guardiantheguardian.com - March 5 at 7:12 AMNEW STATE AVIATION HOLDINGS NAMES CEO AND CFO - PRNewswireprnewswire.com - February 14 at 10:03 AMIxaka Expands Management Team with Multiple Appointments - StreetInsider.comstreetinsider.com - February 11 at 10:17 PMGlobal Cell & Gene Therapy Market Research Report 2022: Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell Therapies - Yahoo Financefinance.yahoo.com - February 2 at 10:49 AMGenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - Business Wirebusinesswire.com - February 2 at 10:49 AMGenSight Biologics Appoints Sissel Rodahl as Senior Vice-President of Commercial Operations to Lead the Launch of LUMEVOQ® in Europe - StreetInsider.comstreetinsider.com - February 1 at 4:01 AMWhy I'm Staying Away From Affinia Therapeutics' IPO For Now - Seeking Alphaseekingalpha.com - January 19 at 12:45 PMNEW STATE CAPITAL ACQUIRES AVEX - PRNewswireprnewswire.com - December 21 at 3:26 PMGlobal Cell Gene Therapy Clinical Trials Report 2028 - Benzinga - Benzingabenzinga.com - December 17 at 9:57 AMBrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs - Yahoo Financefinance.yahoo.com - November 9 at 1:09 AMBrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs - PRNewswireprnewswire.com - November 8 at 3:04 PMGene Therapy Is a Huge Opportunity. It Pays to be Patient. - Barron'sbarrons.com - November 5 at 11:45 PMTesting May Take Awhile, but Gene Therapy Is Poised to Tackle Mass Diseases - Barron'sbarrons.com - November 5 at 3:43 AM$14,996.35Mn by 2028 Healthcare Regulatory Affairs - GlobeNewswireglobenewswire.com - November 3 at 12:28 AMWhat Jaguar Gene Therapy plans for $125M expansion in Research Triangle Park - Triangle Business Journalbizjournals.com - October 30 at 8:20 AMX4 Pharmaceuticals Expands Commercial Leadership Expertise with Appointment of Françoise de Craecker to Board of Directors and Karolyn Park as Vice President, U.S. Commercial - Yahoo Financefinance.yahoo.com - October 19 at 8:17 AMDelix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021 - Yahoo Financefinance.yahoo.com - October 5 at 9:48 PMDelix Therapeutics Named One of Fierce Biotech's "Fierce 15" Companies of 2021 - PRNewswireprnewswire.com - October 4 at 7:39 AMGlobal $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements - Yahoo Financefinance.yahoo.com - September 23 at 12:46 PMGlobal Advanced Therapy Medicinal Products (ATMPs) Market to 2028: Focus on CAR-T, Gene, Cell, Stem Cell Therapy - ResearchAndMarkets.com - Yahoo Financefinance.yahoo.com - September 22 at 3:25 PMCoinFund : Appoints Top Venture Capitalist David Pakman as Managing Partner - marketscreener.commarketscreener.com - September 22 at 10:24 AM5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio Deal - Yahoo Financefinance.yahoo.com - September 14 at 3:38 PMRegenxBio, AbbVie sign commercialization deal for Rockville company's eye disease treatment - Washington Business Journal - Washington Business Journalbizjournals.com - September 13 at 5:28 PMDallas biotech company wins $14.4 million grant from Texas’ cancer research fund - The Dallas Morning Newsdallasnews.com - August 20 at 10:34 PMAGC Biologics Appoints Tony Fraij as the new General Manager/Site Head of the Longmont, Colorado Site - StreetInsider.comstreetinsider.com - August 9 at 2:30 PM Get AveXis News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXS and its competitors with MarketBeat's FREE daily newsletter. Email Address A new way to collect income from stocks (Ad)Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. AVXS Media Mentions By Week AVXS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVXS News Sentiment▼0.000.38▲Average Medical News Sentiment AVXS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVXS Articles This Week▼00▲AVXS Articles Average Week Get AveXis News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VectivBio News Aclarion News Alpha Tau Medical News American Oncology Network News Artelo Biosciences News bioAffinity Technologies News BriaCell Therapeutics News Bullfrog AI News CareCloud News CareCloud News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVXS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AveXis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
